Approved for Treatment of symptoms of seasonal allergic rhinitis and vasomotor rhinitis in adults and children aged 6 years and older. Azelastine nasal 0.15% is a second-generation antihistamine with higher concentration for enhanced efficacy. It blocks H1 receptors and inhibits release of histamine and other inflammatory mediators… Side effects, costs, interactions, manufacturer, and generic…
Loading full data from Know Your Drugs Institute…